This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
28 October 2024
Fenikso Limited
("Fenikso" or "the Company")
Share Buyback Programme
Fenikso Limited (AQSE: FNK), the
The Company has engaged Shard Capital Partners LLP to act as its agent in connection with the Buyback Programme. Purchases under the Buyback Programme will be funded out of the Company's distributable reserves, and payable from the Company's cash reserves or from the receipt of funds under the Lekoil & Gas Investments ("LOGI") Loan entered in to on 31 December 2022 as part of the Fenikso restructuring. All ordinary shares repurchased by the Company under this Buyback Programme will be held in treasury by the Company and then subsequently cancelled.
All purchases under the Buyback Programme will be made in accordance with the resolution passed by shareholders at the AGM. A copy of the circular convening AGM, which contains the full text of the resolution, is available on the Company's website https://feniksoplc.com/
The maximum aggregate number of Ordinary Shares authorised to be purchased is 49,295,278, representing approximately 10% of the issued capital of the Company as of 10 July 2024. The Buyback Programme will expire on the conclusion of the next annual general meeting of the Company or at close of business on 30 September 2025.
All purchases under the Buyback Programme will be announced no later than 7:30 a.m. on the business day following the calendar day on which the purchase occurred.
The Directors of Fenikso accept responsibility for this announcement.
For further information please contact:
Fenikso Limited |
|
Thomas Richardson, Chairman |
info@feniksoplc.com |
First Sentinel Corporate Finance Limited |
|
Brian Stockbridge, Corporate Adviser |
+44 7858 888 007 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.